What are CAR-T Cell Therapies?
What are CAR-T Cell Therapies?Friends of Cancer Research
What are CAR-T Cell Therapies?Friends of Cancer Research
An abstract is unavailable.
Zeynep Eroglu, MD, discusses how findings from a phase 1/2 study of ceritinib and trametinib could help inform future research in melanoma.
AUA TV heads to the Science and Technology Hall to check out AUA’s Emerging Corner – where these start up companies are showcasing their products…
Sunday, May 5, 2024 7:50 AM to 8:00 AM · 10 min. (US/Central)
In a scorching talk, marketing professor and podcaster Scott Galloway dissects the data showing that, by many measures, young people in the US are worse…
Kara N. Maxwell, MD, PhD, discusses the prevalence of germline mutations in racially diverse cohorts of patients with metastatic prostate cancer.
Seeing is understanding: real-time MRI shows stuttering morphologyDr Daniela Ponssen presents the Clinical Picture study, “Visualising the dynamic morphology…
Frontline amivantamab with chemotherapy has been recommended for approval by the CHMP in EGFR exon 20 insertion+ non–small cell lung cancer.
CHMP has voiced its support for the approval of fruquintinib in previously treated metastatic colorectal cancer.
Gerard Walls, MB MRCP MSc FRCR, Queens University in Belfast, UK, discusses the NI-HEART analysis aimed at addressing the challenges of collecting cardiac toxicity events…